These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15657533)

  • 1. Management of hepatitis C patients: a French population-based study.
    Hatem C; Minello A; Martin L; Jooste V; Beurton I; Milan C; Bonithon-Kopp C; Bresson-Hadni S; Miguet JP; Hillon P;
    Gastroenterol Clin Biol; 2004 Nov; 28(11):1101-5. PubMed ID: 15657533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the management of hepatitis C patients appropriate? A population-based study.
    Hatem C; Minello A; Bresson-Hadni S; Jooste V; Evrard P; Obert B; Lepage C; Bonithon-Kopp C; Faivre J; Monnet E; Miguet JP; Hillon P;
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1007-15. PubMed ID: 15813837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Creation of a viral hepatitis B and C in the Côte-d'Or department. Methodology and initial results].
    Minello A; Boschi F; Harb M; Milan C; Faivre J; Hillon P
    Gastroenterol Clin Biol; 1998 Oct; 22(10):766-71. PubMed ID: 9854200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of patients with hepatitis C virus antibodies followed in specialized university hospital units are different from those of patients in the general population. The Research Group of the REBOHC].
    Goegebeur G; Benhamiche AM; Minello A; Rassiat E; Clinard F; Milan C; Faivre J; Hillon P
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1042-6. PubMed ID: 11139673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in prehospital management of ST-segment elevation myocardial infarction from 2002 to 2010 in Cote d'Or: data from the RICO registry (obseRvatoire des Infarctus de Cote d'Or).
    Milojevitch E; Lorgis L; Falvo N; Buffet P; Boidron L; Dentan G; Avena C; Beer JC; Boudenia K; Zeller M; Freysz M; Cottin Y
    Arch Cardiovasc Dis; 2012 Dec; 105(12):649-55. PubMed ID: 23199620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatitis C virus infection in the Poitou- Charentes region].
    Frère T; Verneau A; Besson I; de Bayser L; Dupuychaffray JP; Kitmacher P; Silvain C; Beauchant M
    Gastroenterol Clin Biol; 1999; 23(8-9):887-91. PubMed ID: 10533141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health professionals' perceptions and screening for hepatitis B and C among migrants: a qualitative study in Côte-d'Or, France].
    Enel C; Minello A; Hillon P
    Sante Publique; 2012; 24(4):303-15. PubMed ID: 23043737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Côte d'Or, France.
    Proby C; Minello A; Quantin C; Jooste V; Binquet C; Hägi M; Mounier M; Benzenine E; Hillon P; Maynadié M
    Dig Liver Dis; 2012 Feb; 44(2):160-5. PubMed ID: 21975433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic context, distance to primary care and detection of hepatitis C: a French population-based study.
    Monnet E; Ramée C; Minello A; Jooste V; Carel D; Di Martino V
    Soc Sci Med; 2008 Mar; 66(5):1046-56. PubMed ID: 18164525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary liver cancer in Côte d'Or (France).
    Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
    Int J Epidemiol; 1988 Mar; 17(1):21-6. PubMed ID: 2454894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening and hepatitis C management survey in general medicine in the Alpes-Maritimes and east Var area].
    Ouzan D; Hofliger P; Cavailler P; Mamino C; Tran A
    Gastroenterol Clin Biol; 2003 Jan; 27(1):90-3. PubMed ID: 12594371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
    King LA; Le Strat Y; Meffre C; Delarocque-Astagneau E; Desenclos JC
    Eur J Public Health; 2009 Oct; 19(5):527-33. PubMed ID: 19667051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer of the gallbladder in the Côte d'Or].
    Renard P; Faivre J; Boutron MC; Milan C; Bedenne L; Klepping C
    Gastroenterol Clin Biol; 1987 Mar; 11(3):237-41. PubMed ID: 3582872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system.
    Agostini H; Castera L; Melin P; Cattan L; Roudot-Thoraval F
    Gastroenterol Clin Biol; 2007 Dec; 31(12):1074-80. PubMed ID: 18176360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district].
    Ouzan D; Cavailler P; Hofliger P; Mamino C; Joly H; Tran A
    Gastroenterol Clin Biol; 2003 Apr; 27(4):376-80. PubMed ID: 12759676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus screening in drug users in an addiction out-patient unit].
    Grando-Lemaire V; Goisset P; Sorge F; Trinchet JC; Castera L; Roulot D; Sitruk V; Beaugrand M
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1091-6. PubMed ID: 12520196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In chronic hepatitis C, delays between diagnosis and treatment are linked to the doctor-patient relationship].
    Enel C; Minello A; Jooste V; Pinoit JM; Hillon P
    Med Sci (Paris); 2009 May; 25(5):519-23. PubMed ID: 19480834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
    Coudert B; Chaplain G; Milan C; Janoray P
    Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.